JPMorgan analyst Anupam Rama upgraded Dova Pharmaceuticals Inc (NASDAQ: DOVA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change Upgrades

Ladenburg Thalmann Downgrades Dova Pharmaceuticals Inc (DOVA) to Neutral Following AcquisitionOctober 3, 2019 6:40 AM Form SC TO-C Dova Pharmaceuticals Filed by: Swedish Orphan Biovitrum AB (publ)October 1, 2019 5:13 PM UniCredit to sell 5 billion euros of soured home mortgages next month: sourcesOctober 1, 2019 12:00 PM Form SC TO-C Dova Pharmaceuticals Filed by: Swedish Orphpan Biovitrum AB (publ)October 1, 2019 11:16 AM